Radovich Peter
SEC insider (Form 3/4/5 filer). CIK 0001650131. Director at MBX Biosciences, Inc. (MBX) and 1 other issuer. 25 reported Form 4/5 transactions since Sep 2024; latest on Oct 20, 2026. Located in CARMEL, IN.
Companies Radovich Peter has filed insider reports for
- MBX Biosciences, Inc. (MBX): Director
- Mirum Pharmaceuticals, Inc. (MIRM): Officer, PRESIDENT AND COO
Radovich Peter
CIK: 0001650131
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Oct 20, 2026MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
18.2K shares- - Jun 5, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect17K shares at avg. $19.19$326K - Mar 16, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect16.5K shares at avg. $91.98$1.5M - Mar 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect7.2K shares- - Mar 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect23K shares- - Mar 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect5.9K shares at avg. $15.87$94K - Feb 2, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect2.6K shares at avg. $103.30$272K - Jan 28, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
25.1K shares- - Jan 28, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
16.3K shares- - Jan 28, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectPerformance Restricted Stock Units
34.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 20, 2026 |  MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 18,200 | - | - | Direct |
| Jun 5, 2026 |  MIRM Mirum Pharmaceuticals, Inc. | Exercise | 16,988 | $19.19 | $326,000 | Direct |
| Mar 16, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 16,515 | $91.98 | $1,519,015 | Direct |
| Mar 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 7,220 | - | $0 | Direct |
| Mar 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 23,000 | - | $0 | Direct |
| Mar 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 5,912 | $15.87 | $93,823 | Direct |
| Feb 2, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 2,631 | $103.30 | $271,792 | Direct |
| Jan 28, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 25,120 | - | - | Direct |
| Jan 28, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award Restricted Stock Units | 16,280 | - | - | Direct |
| Jan 28, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award Performance Restricted Stock Units | 34,500 | - | - | Direct |
1-10 of 25 transactions